| Control (n = 23) | Sepsis (n = 27) | Survival (n = 8) | Non-survival (n = 19) | P valuea S × NS |
---|---|---|---|---|---|
Demographic data | Â | Â | Â | Â | Â |
Age, mean ± SD, year | 65 ± 14.6 | 62.4 ± 12.8 | 60 ± 15.8 | 63.4 ± 11.6 | 0.5357 |
Sex (% of male) | 60.9 | 70.4 | 87.5 | 63.2 | 0.3645 |
Place of acquired infection (%) | Â | Â | Â | Â | Â |
 Prior to ICU | NA | 77.8 | 87.5 | 73.68 | 0.6334 |
 ICU acquired | NA | 22.2 | 12.5 | 26.32 |  |
Severity of disease | Â | Â | Â | Â | Â |
Septic shock (%) | NA | 77.8 | 87.5 | 73.68 | 0.6334 |
Severity scores, mean ± SD |  |  |  |  |  |
 Apache II | NA | 17.1 ± 6.5 | 15.6 ± 7.6 | 17.7 ± 6 | 0.4483 |
 SOFA | NA | 8.3 ± 2.9 | 8.0 ± 2.9 | 8.4 ± 2.9 | 0.7709 |
 Delta-SOFA (D3-D0) | NA | (−) 0.4 ± 3.1 | (−) 1.9 ± 3.4 | 0.7 ± 2.8 | 0.0666 |
Organ dysfunction (%) | Â | Â | Â | Â | Â |
 Cardiovascular | NA | 88.9 | 87.5 | 89.5 | 1 |
 Renal | NA | 37 | 37.5 | 36.8 | 1 |
 Respiratory | NA | 85.2 | 75 | 89.5 | 0.5583 |
 Hematological | NA | 11.1 | 0 | 15.8 | 0.5323 |
 Hepatological | NA | 33.3 | 25 | 36.8 | 0.6758 |
 Central nervous system | NA | 44.4 | 50 | 42 | 1 |
Underlying conditions | Â | Â | Â | Â | Â |
Chronic comorbidity (%) | Â | Â | Â | Â | Â |
 AIDS | NA | 0 | 0 | 0 | – |
 COPD | NA | 15.4 | 12.5 | 16.7 | 1 |
 Diabetes | NA | 30.8 | 12.5 | 38.9 | 0.3602 |
 Chronic renal disease | NA | 7.7 | 0 | 11.1 | 1 |
 Cardiovascular insufficiency | NA | 11.5 | 0 | 16.7 | 0.5292 |
Drugs (%) | Â | Â | Â | Â | Â |
 Corticosteroids | NA | 37 | 50 | 31.6 | 0.4147 |